Foresite Capital Management IV, LLC Diversified Active

Name: Foresite Capital Management IV, LLC Q4 2024 13F Filing | 13F Explorer
Creator: Foresite Capital Management IV, LLC
Published: 2025-02-14

Location: West Hollywood, CA

CIK: 0001704132 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $109M (100.0% shares, 0.0% debt)

Holdings (4)

PHVS Pharvaris N.V. 77.5%

Value $84.31M Shares 4,397,881 Est. Cost $27.29 Unrealized -24.6%

KURA Kura Oncology, Inc. 13.8%

Value $15.04M Shares 1,726,882 Est. Cost $20.39 Unrealized -29.4%

— Lyell Immunopharma, Inc. 4.9%

Value $5.328M Shares 8,325,000 Est. Cost $16.24 Unrealized —

RLAY Relay Therapeutics Inc. 3.8%

Value $4.12M Shares 1,000,000 Est. Cost $7.47 Unrealized -27.2%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	Pharvaris N.V.	4,397,881	$84.31M	77.5%	$27.29	-24.6%	COM	N69605108
KURA	Kura Oncology, Inc.	1,726,882	$15.04M	13.8%	$20.39	-29.4%	COM	50127T109
—	Lyell Immunopharma, Inc.	8,325,000	$5.328M	4.9%	$16.24	—	COM	55083R104
RLAY	Relay Therapeutics Inc.	1,000,000	$4.12M	3.8%	$7.47	-27.2%	COM	75943R102